IperionX (IPX) Q4 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 TU earnings summary
29 Jul, 2026Executive summary
Virginia operations maintained 24/7 titanium powder production, supporting customer qualification and product programs.
Commissioned a new 300-ton SACMI press, tripling powder metallurgy capacity and expanding product range.
Advanced customer programs in defense, aerospace, automotive, and industrial sectors, including successful prototype deliveries.
Completed the U.S. Government-supported Titan Definitive Feasibility Study, confirming strong project economics for critical minerals.
Acquired the Atlas critical minerals asset, expanding the resource base and infrastructure for integrated development.
Financial highlights
Ended the quarter with $35.2 million in cash; pro-forma cash post-offering and reimbursements is ~$84 million.
Gross proceeds of ~$50 million raised in July 2026 via a U.S. public offering.
Net cash used in operating activities for the quarter was $(11.9) million.
Receipts from customers totaled $8,000 for the quarter.
U.S. Government grants and reimbursements contributed $803,000 in the quarter.
Outlook and guidance
Targeting a run-rate production capacity of 200 tpa titanium powder by end of 2026, with expansion to 1,400 tpa supported by government funding.
Integrated Atlas-Titan economic assessment expected by end of 2026 to quantify capital and schedule benefits.
GenX™ continuous HAMR™ development ongoing, aiming for improved throughput and cost efficiency.
Latest events from IperionX
- Ramping titanium output to 200 tpa, advancing GenX, and accelerating Atlas for supply chain resilience.IPX
Investor update - Scaling up as a leading U.S. titanium and critical minerals supplier with strong government backing.IPX
Company presentation - U.S. titanium production scales rapidly with new tech, strong demand, and government support.IPX
Investor update - Continuous titanium production ramped up, with strong cash and government support for expansion.IPX
Q3 2026 TU - HAMR furnace commissioning, DoD funding, and Ford contract drive growth amid higher net loss.IPX
H2 2024 - Expanded U.S. titanium production, secured major government funding, and increased net loss on higher R&D.IPX
H1 2026 - Titanium manufacturing expansion accelerates with robust funding and new defense contracts.IPX
Q2 2026 TU - Titanium production capacity up 60%, with major U.S.-backed expansion and strong cash position.IPX
Q1 2026 TU - Innovative titanium supply chain reshoring accelerates with strong funding and market expansion.IPX
Sidoti's Small-Cap Virtual Conference